These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 9093140)

  • 1. A medical approach to management of spontaneous abortion using misoprostol. Extending misoprostol treatment to a maximum of 48 hours can further improve evacuation of retained products of conception in spontaneous abortion.
    Chung T; Leung P; Cheung LP; Haines C; Chang AM
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):248-51. PubMed ID: 9093140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the psychologic impact and client satisfaction of surgical treatment with medical treatment of spontaneous abortion: a randomized controlled trial.
    Lee DT; Cheung LP; Haines CJ; Chan KP; Chung TK
    Am J Obstet Gynecol; 2001 Oct; 185(4):953-8. PubMed ID: 11641684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.
    Grønlund A; Grønlund L; Clevin L; Andersen B; Palmgren N; Lidegaard Ø
    Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1060-5. PubMed ID: 12421175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A viable alternative to surgical vacuum aspiration: repeated doses of intravaginal misoprostol over 9 hours for medical termination of pregnancies up to eight weeks.
    Singh K; Fong YF; Dong F
    BJOG; 2003 Feb; 110(2):175-80. PubMed ID: 12618162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expectant, medical, or surgical management of first-trimester miscarriage: a meta-analysis.
    Sotiriadis A; Makrydimas G; Papatheodorou S; Ioannidis JP
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1104-13. PubMed ID: 15863551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility after non-surgical management of the symptomatic first-trimester spontaneous abortion.
    Fontanarosa M; Galiberti S; Fontanarosa N
    Minerva Ginecol; 2007 Dec; 59(6):591-4. PubMed ID: 18043572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized outpatient clinical trial of medical evacuation and surgical curettage in incomplete miscarriage.
    Sahin HG; Sahin HA; Kocer M
    Eur J Contracept Reprod Health Care; 2001 Sep; 6(3):141-4. PubMed ID: 11763977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of misoprostol for early pregnancy failure.
    Tang OS; Ho PC
    Curr Opin Obstet Gynecol; 2006 Dec; 18(6):581-6. PubMed ID: 17099326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misoprostol for uterine evacuation in patients with early pregnancy failures.
    Murchison A; Duff P
    Am J Obstet Gynecol; 2004 May; 190(5):1445-6. PubMed ID: 15167864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MisoREST: surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: a randomized controlled trial.
    Lemmers M; Verschoor MA; Oude Rengerink K; Naaktgeboren C; Opmeer BC; Bossuyt PM; Huirne JA; Janssen CA; Radder C; Klinkert ER; Langenveld J; Catshoek R; Van der Voet L; Siemens F; Geomini P; Van Hooff MH; Van der Ploeg JM; Coppus SF; Ankum WM; Mol BW;
    Hum Reprod; 2016 Nov; 31(11):2421-2427. PubMed ID: 27591236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate and misoprostol for early abortion.
    Schaff EA; Eisinger SH; Franks P; Kim SS
    Fam Med; 1996 Mar; 28(3):198-203. PubMed ID: 8900553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatment with misoprostol for early failure of pregnancies after assisted reproductive technology: a promising treatment option.
    Machtinger R; Stockheim D; Seidman DS; Lerner-Geva L; Dor J; Schiff E; Shulman A
    Fertil Steril; 2009 May; 91(5):1881-5. PubMed ID: 18455163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
    Chawdhary R; Rana A; Pradhan N
    J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion.
    Schaff EA; Stadalius LS; Eisinger SH; Franks P
    J Fam Pract; 1997 Apr; 44(4):353-60. PubMed ID: 9108832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised trial of surgical, medical and expectant management of first trimester spontaneous miscarriage.
    Shelley JM; Healy D; Grover S
    Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):122-7. PubMed ID: 15760312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management of early pregnancy failure: how to treat and what to expect.
    Dempsey A; Davis A
    Semin Reprod Med; 2008 Sep; 26(5):401-10. PubMed ID: 18825608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracervical application of the nitric oxide donor isosorbide dinitrate for induction of cervical ripening: a randomised controlled trial to determine clinical efficacy and safety prior to first trimester surgical evacuation of retained products of conception.
    Arteaga-Troncoso G; Villegas-Alvarado A; Belmont-Gomez A; Martinez-Herrera FJ; Villagrana-Zesati R; Guerra-Infante F
    BJOG; 2005 Dec; 112(12):1615-9. PubMed ID: 16305563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose misoprostol used in outpatient management of first trimester spontaneous abortion.
    Sifakis S; Angelakis E; Vardaki E; Fragouli Y; Koumantakis E
    Arch Gynecol Obstet; 2005 Sep; 272(3):183-6. PubMed ID: 15909189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing women's preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Hentzen JEKR; Verschoor MA; Lemmers M; Ankum WM; Mol BWJ; van Wely M
    Hum Reprod; 2017 Aug; 32(8):1674-1683. PubMed ID: 28575402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.